Subgroup | Metoclopramide group ( n = 100) | Domperidone group ( n = 99) | Control group ( n = 99) | Total ( n = 298) | P value |
---|---|---|---|---|---|
Age | |||||
<60 years | 22/38 (57.9)* | 19/35 (54.3)* | 11/41 (26.8) | 52/114 (45.6) | 0.0100 |
≥60 years | 33/62 (53.2)* | 32/64 (50.0)* | 16/58 (27.6) | 81/184 (44.0) | 0.0090 |
Sex | |||||
 Male | 38/67 (56.7)** | 28/58 (48.3)* | 17/72 (23.6) | 83/197 (42.1) | 0.0002 |
 Female | 17/33 (51.5) | 23/41 (56.1) | 10/27 (37.0) | 50/101 (49.5) | 0.2944 |
APACHE II score | |||||
  < 20 | 31/45 (68.9)** | 27/43 (62.8)* | 14/43 (32.6) | 72/131 (55.0)# | 0.0013 |
  ≥ 20 | 24/55 (43.6) | 24/56 (42.9) | 13/56 (23.8) | 61/167 (36.5) | 0.0398 |
SOFA score | |||||
  < 12 | 39/66 (59.1)* | 37/68 (54.4)‡ | 24/66 (36.4) | 100/200 (50.0)†| 0.0221 |
  ≥ 12 | 16/34 (47.1)** | 14/31 (45.2)** | 3/33 (9.1) | 33/98 (33.7) | 0.0012 |
Neurological diseases | |||||
 Yes | 27/48 (56.3)** | 19/41 (46.3)∫ | 9/39 (23.1) | 55/128 (43.0) | 0.0069 |
 No | 28/52 (53.8)* | 32/58 (55.2)* | 18/60 (30.0) | 78/170 (45.9) | 0.0089 |
Sepsis | |||||
 Yes | 9/14 (64.3)* | 7/11 (63.6)* | 2/13 (15.4) | 18/38 (47.4) | 0.0173 |
 No | 46/86 (53.5)** | 44/88 (50.0)* | 25/86 (29.1) | 115/260 (44.2) | 0.0023 |
Use of sedatives or analgesics | |||||
 Yes | 15/35 (42.9) | 16/37 (43.2) | 12/38 (31.6) | 43/110 (39.1) | 0.5023 |
 No | 40/65 (61.5)** | 35/62 (56.5)** | 15/61 (24.6) | 90/188 (47.9) | 0.0001 |
Use of vasopressors | |||||
 Yes | 10/24 (41.7) | 8/21 (38.1) | 4/25 (16.0) | 22/70 (31.4)¶ | 0.1129 |
 No | 45/76 (59.2)** | 43/78 (55.1)** | 23/74 (31.1) | 111/228 (48.7) | 0.0009 |
Mechanical ventilation | |||||
 Yes | 33/72 (45.8) | 31/66 (47.0) | 19/68 (27.9) | 83/206 (40.3)‖ | 0.0397 |
 No | 22/28 (78.6)** | 20/33 (60.6)* | 8/31 (25.8) | 50/92 (54.3) | 0.0002 |